Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Role of the Diabetes Care and Education Specialist in CGM
  • CME
  • CE

Hear about the benefits of continuous glucose monitoring (CGM) and tips for getting patients and providers on board with this advanced technology.
person default
Carla Cox, PhD, RD, FAADE
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE
Physicians: maximum of 0.25 AMA PRA Category 1 Credits
Registered Nurses: 0.25 Nursing contact hours
Pharmacists: 0.25 contact hours (0.025 CEUs)
Released: March 31, 2020 Expiration: March 30, 2021

Podcast Notes

Continuous glucose monitoring (CGM) is a great tool that improves clinical outcomes for people with diabetes; these individuals are often happy to get this new technology.

However, there can be some initial barriers that both people with diabetes and clinicians need to overcome.

BARRIER 1: Wearing something on the body so other people know the person has diabetes.

SOLUTION 1: Let the person see the size of different devices through demonstrations and show possible discreet places on the body where they can be worn.

  • Consider starting with a professional CGM, owned by the clinic and borrowed by the individual for up to 14 days, so that he or she can get a feel for what it is like.
  • Consider a CGM that can be integrated with a smart pen instead of an insulin pump, so the individual has only 1 device to wear.

BARRIER 2: Cost of the CGM.

SOLUTION 2: Find out insurance requirements to see if the CGM can be covered and what is required for coverage.

  • A disposable sensor is a lower cost option. There are coupons available and some pharmacies sell for lower costs.
  • Professional CGM is an underused insurance benefit that is often covered multiple times per year if used on a short- term basis.

BARRIER 3: Too much information from CGM can be overwhelming for the individual.

SOLUTION 3: Make sure alarms and alerts are set appropriately to avoid alarm fatigue—have the alerts go off when it matters most, like during hypoglycemia. Look at the device at key times only, like before meals, before bedtime, and before activities like exercising and driving, and utilize CGM to determine glycemic trends.

BARRIER 4: Clinicians are hesitant to embrace CGM technology.

SOLUTION 4: There are various resources available to help clinicians understand CGM technology and to assist in integrating CGM into their practice settings.

  • Online tutorials, industry representatives, and diabetes care and education specialists can help clinicians understand how to start people with diabetes on CGM and how to interpret the data.
  • CPT codes are now available to help support the cost of additional staff to train the individual on the devices and cover the cost of review and interpretation.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Collaborate with the diabetes healthcare team (ie, specialist, primary care clinician, diabetes educator) to improve adoption of CGM devices in practice

Information on this Educational Activity

Faculty

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE

Clinical Pharmacy Specialist/CGM Program Coordinator
Department of Endocrinology, Diabetes, and Metabolism
Cleveland Clinic Diabetes Center
Cleveland, Ohio

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDE, has disclosed that she has received consulting fees from Dexcom, LifeScan, and Novo Nordisk.
Carla Cox, PhD, RD, FAADE

Certified Diabetes Educator and Clinical Dietitian
Mountain Vista Medicine
South Jordan, Utah

Carla Cox, PhD, RD, FAADE, has no relevant conflicts of interest to report.

Staff

Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.
Anne Roc, PhD
Director, Scientific Services
Anne Roc, PhD, has no relevant conflicts of interest to report.

Target Audience

This activity is intended for diabetes specialists, primary care clinicians, and other healthcare providers who are part of the diabetes care team including nurses, diabetes care and education specialists, pharmacists, and registered dietitians.

Goal

The goal of this activity is to improve learner knowledge and competence in managing glycemic control in patients with diabetes by providing timely treatment intensification according to the guidelines and applying evidence-based treatment strategies for patients with diabetes.

Physician Continuing Medical Education

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nursing Continuing Education

The Association of Diabetes Care & Education Specialists is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.  This program provides 0.25 contact hour of continuing education credit.

Provider approved by the California Board of Registered Nursing, Provider # 10977, for 0.25 Contact Hour. RNs must retain this document for 4 years after the activity concludes.

Pharmacist Continuing Education

The Association of Diabetes Care & Education Specialists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 0.25 contact hours (0.025 CEU's) of continuing education credit.

ACPE Universal Activity Number: 0069-9999-20-041-H01-P

Effective date: March 31, 2020 to March 31, 2021

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 31, 2020, through March 30, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Concise CCO expert commentary on potential side effects with GLP-1 receptor agonists in patients with type 2 diabetes

Martin J. Abrahamson, MD, FACP Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: September 1, 2020 Expired: August 31, 2021

Neil Skolnik, MD reviews GLP-1 RAs to address elevated A1C, obesity, and CV risk, plus strategies to improve tolerability, adherence

John J. Russell, MD Neil Skolnik, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Nurse Practitioners: 1.0 AANP contact hour Released: July 13, 2020 Expired: July 12, 2021

Hyperglycemia can be a deadly complication for anyone with diabetes, but there are tools that can reduce this risk including GLP-1 medications. Learn more today.

Released: July 9, 2020

CME commentary: GLP-1 receptor agonists to prevent major cardiovascular adverse events (MACE) in type 2 diabetes (T2D), cardiovascular disease (CVD)

Anne Peters, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: June 8, 2020 Expired: June 7, 2021

Acknowledgements

Provided by Endocrine Society

For questions about content or obtaining CME credit, please contact the Endocrine Society at www.education.endocrine.org/contact.

Produced in collaboration with
Supported by an educational grant from
Lilly

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue